Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

Eur Respir J. 2012 Mar;39(3):772-5. doi: 10.1183/09031936.00113011.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Female
  • France
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Idiopathic Pulmonary Fibrosis / physiopathology
  • Male
  • Middle Aged
  • Octreotide / adverse effects
  • Octreotide / blood
  • Octreotide / therapeutic use*
  • Respiratory Function Tests
  • Severity of Illness Index
  • Treatment Failure

Substances

  • Biomarkers
  • Gastrointestinal Agents
  • Octreotide

Associated data

  • ClinicalTrials.gov/NCT00463983